66047-10-7 Usage
Uses
Used in Pharmaceutical Industry:
Pyrido[2,3-d]pyrimidine-6-carboxylic acid, 2-[4-[(4-aminophenyl)methyl]-1-piperazinyl]-8-ethyl-5,8-dihydro-5-oxo-, monopotassium salt is used as an active pharmaceutical ingredient for the development of medications targeting psychiatric disorders. Its antipsychotic and antidepressant effects make it a valuable compound in the treatment of conditions such as schizophrenia, bipolar disorder, and major depressive disorder.
Used in Clinical Settings:
In clinical settings, Pyrido[2,3-d]pyrimidine-6-carboxylic acid, 2-[4-[(4-aminophenyl)methyl]-1-piperazinyl]-8-ethyl-5,8-dihydro-5-oxo-, monopotassium salt is used as a therapeutic agent for patients suffering from psychiatric disorders. It may be administered in the form of tablets or injections, and its prescription is typically done under close medical supervision to monitor potential side effects and interactions with other medications.
Used in Research and Development:
Pyrido[2,3-d]pyrimidine-6-carboxylic acid, 2-[4-[(4-aminophenyl)methyl]-1-piperazinyl]-8-ethyl-5,8-dihydro-5-oxo-, monopotassium salt is also utilized in research and development for the discovery of new psychiatric medications. Its complex molecular structure and pharmacological properties make it an interesting candidate for further investigation into its potential applications and mechanisms of action in the treatment of various psychiatric conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 66047-10-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,6,0,4 and 7 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 66047-10:
(7*6)+(6*6)+(5*0)+(4*4)+(3*7)+(2*1)+(1*0)=117
117 % 10 = 7
So 66047-10-7 is a valid CAS Registry Number.
66047-10-7Relevant academic research and scientific papers
2-[4-(P-Aminobenzyl)-1-piperazinyl]-8-ethyl-5,8-dihydro-5-oxopyrido[2,3-d]py
-
, (2008/06/13)
2-[4-(P-Aminobenzyl)-1-piperazinyl]-8-ethyl-5,8-dihydro-5-oxopyrido-[2,3-d]pyrimidine-6-carboxylic acid, and its pharmaceutically acceptable salt. This novel compound can be prepared by reacting a compound of the formula STR1 wherein R is a hydrogen atom
